eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-SYRE-Spyre Therapeutics Inc

Spyre Therapeutics Inc SYRE

‎$‎33.43-0.30(-0.89%)(1D)
Delayed prices by NASDAQin USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
59.00
Based on analysts who covered SYRE
Invest in Spyre Therapeutics Inc
Today
Create an eToro account to buy SYRE stock on a secure, user-friendly, multi-asset trading platform.
Buy Spyre Therapeutics Inc
Spyre Therapeutics Inc SYRE

SYRE Stock Price Chart

‎1.92‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset positive trend

The Spyre Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Spyre Therapeutics Inc share price today is ‎$‎33.43, reflecting a ‎-0.89‎% change over the last 24 hours and ‎1.03‎% over the past week. The current market capitalization of SYRE is ‎$‎2.62B with an average volume in the last three months of 750777.74. The stock has a P/E ratio of -15.49 and a dividend yield of 0%. With the stock’s beta sitting at 1.69
SYRE Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎2.62B

Day’s Range
i
Shows the high and low prices of the day.
‎$‎33.4 - ‎$‎34.16

52W Range
i
Shows the high and low prices of the last year.
‎$‎11.43 - ‎$‎40

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
750777.74

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-15.49

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎33.73

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-2.18

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.69

How can I buy Spyre Therapeutics Inc stocks?

To purchase Spyre Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Spyre Therapeutics Inc (SYRE) page and place an order to buy Spyre Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Spyre Therapeutics Inc
Invest in Spyre Therapeutics Inc
Today
Create an eToro account to buy SYRE stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of SYRE is ‎$‎33.43.
The average price target for Spyre Therapeutics Inc is ‎$‎59.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Spyre Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Spyre Therapeutics Inc is ‎$‎2.62B
Based on 5 analysts offering recommendations for SYRE in the last 3 months, the overall consensus is Strong Buy.
Scroll to top